348150 Stock Chart & Stats
₩2980.00
-₩35.00(-1.16%)
―
--
Day’s Range― - ―
52-Week Range₩2,310.00 - ₩8,730.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)51.41K
Market Cap
₩58.55B
Enterprise Value₩47.86K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta>-0.01
Next Earnings
Nov 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-195.69
Shares Outstanding19,418,888
10 Day Avg. Volume27,073
30 Day Avg. Volume51,411
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
348150 FAQ
What was KoBioLabs, Inc.’s price range in the past 12 months?
KoBioLabs, Inc. lowest stock price was ₩2310.00 and its highest was ₩8730.00 in the past 12 months.
What is KoBioLabs, Inc.’s market cap?
KoBioLabs, Inc.’s market cap is ₩58.55B.
When is KoBioLabs, Inc.’s upcoming earnings report date?
KoBioLabs, Inc.’s upcoming earnings report date is Nov 12, 2026 which is in 84 days.
How were KoBioLabs, Inc.’s earnings last quarter?
KoBioLabs, Inc. released its earnings results on Aug 13, 2026. The company reported -₩195.693 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is KoBioLabs, Inc. overvalued?
According to Wall Street analysts KoBioLabs, Inc.’s price is currently Undervalued.
Does KoBioLabs, Inc. pay dividends?
KoBioLabs, Inc. does not currently pay dividends.
What is KoBioLabs, Inc.’s EPS estimate?
KoBioLabs, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does KoBioLabs, Inc. have?
KoBioLabs, Inc. has 19,418,888 shares outstanding.
What happened to KoBioLabs, Inc.’s price movement after its last earnings report?
KoBioLabs, Inc. reported an EPS of -₩195.693 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.664%.
Which hedge fund is a major shareholder of KoBioLabs, Inc.?
Currently, no hedge funds are holding shares in KR:348150
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
SELVAS Healthcare, Inc.
―
PanGen Biotech, Inc.
―
Eone Diagnomics Genome Center Co., Ltd.
―
Aptamer Sciences, Inc.
―
PROTIA INC.
―